Predicting response to chemotherapy and likelihood of cancer recurrence is the name of the game these days.  New tools are currently available for women diagnosed with breast cancer and include the OncotypeDX and Mammaprint tests.  Both test help predict which early breast cancers are most likely to recur and can help guide treatment options.  There are key differences between the tests so be

read more: Predicting response to chemotherapy